Category: Latest News
-
Procter & Gamble stock hits 52-week low at $156.58 amid market headwinds
Shares of Procter & Gamble Co. (NYSE:PG) fell to a 52-week low of $156.58, highlighting a tough stretch for the consumer goods leader. The stock has declined 6.1% over the past year as the company grapples with macroeconomic pressures and evolving consumer preferences. This recent dip underscores broader investor caution across the sector amid economic…
-
Ralph Lauren shares soar to record high of $289.34
Ralph Lauren Corp (NYSE:RL) Class A stock hit a new all-time high of $289.34, marking a major achievement for the luxury fashion brand. Backed by a market cap of $17.52 billion and a solid gross profit margin of 68.55%, the company’s latest performance signals strong investor confidence and financial health. With a 61.3% gain over…
-
Alphabet shares climb as Google brings Gemini AI to smartwatches running Wear OS
Alphabet Inc. (NASDAQ:GOOGL) saw its stock rise 2% after Google revealed it is expanding the availability of its Gemini AI assistant to smartwatches powered by Wear OS, further embedding its artificial intelligence tools into everyday tech. The move brings Gemini to wearable devices from brands such as Pixel, Samsung (KS:005930), OPPO, OnePlus, and Xiaomi (OTC:XIACF).…
-
Nvidia becomes world’s first $4 trillion company as AI momentum accelerates
NVIDIA Corp. (NASDAQ:NVDA) made history on Wednesday, becoming the first publicly traded company to surpass a $4 trillion market capitalization. The chipmaker’s stock gained 2.7%, closing at $164.32—just enough to lift its valuation above the key $163.93 level required to reach the milestone. This latest rally comes amid surging investor enthusiasm for artificial intelligence, with…
-
Sanmina Corporation stock hits a new 52-week peak at $103.16
Sanmina Corporation’s (NASDAQ:SANM) shares surged to a fresh 52-week high, reaching $103.16 and reflecting a market valuation of approximately $5.5 billion. Over the last year, the stock has gained an impressive 51.72%, with a strong year-to-date return of 35.1%, signaling robust investor confidence. Trading at a price-to-earnings ratio of 23, Sanmina’s stock performance highlights the…
-
Broadcom Stock Hits Record High of $277.76
Broadcom Inc. (NASDAQ:AVGO) reached a new all-time high, with shares climbing to $277.76 and pushing its market cap to an impressive $1.3 trillion. This milestone highlights a strong year for the semiconductor giant, with its stock soaring nearly 59% over the past 12 months. Broadcom’s robust revenue growth of 33.85% and a track record of…
-
Apple stock drops after White House trade advisor says company thinks it’s too big to tariff
Apple (NASDAQ:AAPL) shares dipped 0.5% in early trading Wednesday following remarks from White House trade advisor Peter Navarro, who suggested the tech giant believes it is “too big to tariff.” Speaking on Fox Business, Navarro commented on the current trade negotiations, saying, “Apple thinks it’s ’too big to tariff’,” hinting that the company may expect…
-
Microsoft Stock Hits Record High of $501.46 Amid Strong Growth and Strategic Moves
Microsoft Corporation (NASDAQ:MSFT) shares reached a new all-time peak, closing at $501.46. This milestone reflects solid investor confidence fueled by robust revenue growth of 14.13% over the past year and a strong gross profit margin of 69%. Over the last 12 months, Microsoft’s stock climbed 7.33%, demonstrating steady performance in a highly competitive tech landscape.…
-
CoreWeave Leads Market with Scaled Launch of NVIDIA RTX PRO 6000 Blackwells; Shares Rise
CoreWeave Inc. (NASDAQ:CRWV) shares edged up 1.7% on Wednesday after the AI-focused cloud provider became the first to deploy NVIDIA’s new RTX PRO 6000 Blackwell Server Edition at scale. This launch solidifies CoreWeave’s position at the cutting edge of high-performance AI infrastructure, aligning with its ambitious push to dominate GPU cloud services. NVIDIA Corporation (NASDAQ:NVDA)…
-
Hims & Hers Shares Gain on Plans for Canadian Launch Featuring Generic Semaglutide
Hims & Hers Health (NYSE:HIMS) shares climbed 2% on Wednesday following the announcement of its planned market entry into Canada in 2026, timed with the expected global debut of generic semaglutide. The company’s Canadian rollout aims to coincide with the availability of lower-cost generic versions of the widely used weight loss drug, offering potentially significant…